[1]吴昭克,朱勇,李艺彬,等.壮骨通痹丸与硫酸氨基葡萄糖治疗 膝骨关节炎的比较研究[J].中医正骨,2012,24(07):20-22.
 WU Zhao-ke*,ZHU Yong,LI Yi-bin,et al.Comparative study on the curative effects and safety between ZHUANGGU TONGBI pill and glucosamine sulfate capsules in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(07):20-22.
点击复制

壮骨通痹丸与硫酸氨基葡萄糖治疗 膝骨关节炎的比较研究()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第24卷
期数:
2012年07期
页码:
20-22
栏目:
临床研究
出版日期:
2012-07-30

文章信息/Info

Title:
Comparative study on the curative effects and safety between ZHUANGGU TONGBI pill and glucosamine sulfate capsules in the treatment of knee osteoarthritis
作者:
吴昭克朱勇李艺彬徐福东
福建省泉州市正骨医院,福建 泉州 362000
Author(s):
WU Zhao-ke*ZHU YongLI Yi-binXU Fu- dong.*
Quanzhou Osteopathy Hospital,Quanzhou 362000,Fujian,China
关键词:
骨关节炎膝 壮骨通痹丸 硫酸氨基葡萄糖 治疗临床研究性
Keywords:
Osteoarthritisknee ZHUANGGU TONGBI PILL Glucosamine sulfate Therapiesinvestigational
摘要:
目的:观察对比壮骨通痹丸与硫酸氨基葡萄糖治疗膝骨关节炎的临床疗效和安全性。方法:将符合要求的120例患者随机分 成治疗组和对照组,每组60例。治疗组口服壮骨通痹丸治疗,对照组口服硫酸氨基葡萄糖胶囊治疗,共治疗12周。治疗后观察对比 2组患者的Lequesne指数、临床疗效及不良反应发生情况。结果:①Lequesne指数。治疗前2组患者Lequesne指数比较,差异无统 计学意义(t=0.954,P=0.348); 治疗后2组患者的Lequesne指数均减少,其中治疗组减少程度更明显(t=6.228,P=0.000)。②临床 疗效。治疗后2组患者的症状体征均改善,治疗组临床疗效优于对照组(χ2=7.026,P=0.008)。③不良反应。治疗期 间2组患者均未出现过敏反应。治疗组2例患者出现便秘,1例患者血压升高,1例患者心率加快; 对照组3例患者出现恶心、便秘,1 例患者心率加快,1例轻度肝功能受损。经对症处理后,2组患者的不良反应均消失。2组患者不良反应发生率比较,差异无统计学 意义(χ2=0.100,P=0.752)。结论:壮骨通痹丸能明显改善膝骨关节炎患者的临床症状体征及关节功能,且治疗期间 无严重不良反应,具有一定的临床应用价值。
Abstract:
Objective:To observe and compare the clinical curative effects and safety between ZHUANGGU TONGBI pill and glucosamine sulfate capsules in the treatment of knee osteoarthritis(KOA).Methods:One hundred and twenty patients met the requirements were randomly divided into treatment group and control group,60 cases in each group.Patients in the treatment group were administrated with ZHUANGGU TONGBI pill,while the others in the control group were administrated with glucosamine sulfate capsules,treatment of 12 weeks in total.Lequesne index,clinical curative effects and adverse reactions during the treatment period of the patients were observed and compared between the 2 groups after the treatment.Results:①There was no statistical difference in Lequesne index between the 2 groups before the treatment(t=0.954,P=0.348); after the treatment, the Lequesne index of the 2 groups were all reduced and that of the treatment group reduced more(t=6.228,P=0.000).②After the treatment,symptoms and signs of patients in the 2 groups were all improved,and clinical curative effect of treatment group was better than that of control group(χ2=7.026,P=0.008).③No anaphylaxis was found in the 2 groups during the treatment period.Two patients with constipation,1 case with increased blood pressure and 1 case with elevated heart rate were found in the treatment group; while 3 cases with nausea and constipation,1 case with elevated heart rate and 1 case with lightly impaired liver function were found in the control group.After symptomatic treatment,the adverse reactions of the 2 groups were all disappeared.There was no statistical difference in adverse reaction ratio between the 2 groups (χ2=0.100,P=0.752).Conclusion:ZHUANGGU TONGBI pill can significantly improve the clinical symptoms and signs and the joint functions for the KOA patients without serious adverse reactions during the treatment period,therefore,it has a certain application value in the treatment of KOA.

参考文献/References:

[1] 陈大宇,曹亚飞,麦庆春,等.中药热奄包治疗膝骨关节炎的临床观察[J].中医正骨,2011,23(6):6-8.
[2] 施桂英,关节炎概要[M].北京:中国医药科技出版社,2000:331-336.
[3] 李亮晖,杜宇康,赖小荣,等.Lequesne指数和髌股骨关节功能评分对膝骨性关节炎患者的评价比较[J].海南医学,2011,22 (8):17-19.
[4] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994:30-31.
[5] 何伟,张俐,王维佳,等.骨病临床研究[M].北京:北京科学技术出版社,2006:135.
[6] 贺宪,魏春山,蔡智刚,等.膝骨性关节炎的病机和防治机制探讨[J].山东中医杂志,2005,24(2):73-75.
[7] 王国新,陈文红,励建安,等.硫酸氨基葡萄糖片治疗膝骨性关节炎多中心双盲随机平行对照临床试验[J].中国临床药理学杂 志,2004,20(5):328-331.
[8] 王哲,方家,付文轶.硫酸氨基葡萄糖治疗膝关节骨性关节炎近期疗效评价[J].实用药物与临床,2009,12(6):397-398.
[9] 史昌乾,姜辉,胥学冰,等.硫酸氨基葡萄糖钾胶囊治疗退行性骨性关节炎613例临床效果评价[J].武警医学院学报,2011,20 (5):362-363.

相似文献/References:

[1]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[2]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[3]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[4]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):9.
[5]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[6]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[7]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式 和理论体系[J].中医正骨,2015,27(07):1.
[8]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗 骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):6.
[9]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):15.
[10]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):27.

备注/Memo

备注/Memo:
2012-01-13收稿 2012-04-18修回
更新日期/Last Update: 2012-07-30